ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Breast cancer session was ASCO equivalent of a rock concert, discussant says.

May 27, 2005

Concepts Approved For New Technology In Computers, Recompetition

November 6, 1987

Mammography Summit Planned For June In Milan.

March 1, 2002

Farber Grant Probe Misses Real Story

July 8, 1977

Cullen Credits Staff With Success Of STCP, Strong Prevention Program a NCI

May 19, 1989

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010